JezK

Edit File: 1620193859.M882199P270898.mocha3025.mochahost.com,S=80808,W=82540:2,S

Envelope-to: ahf-finance@jack.ngo,
 ahmad@jack.ngo,
 dr.safar@jack.ngo,
 fatima.qasimi@jack.ngo,
 finance.advisor@jack.ngo,
 ghani@jack.ngo,
 hamdard@jack.ngo,
 logistic.manager@jack.ngo,
 mirzaee@jack.ngo,
 musawy@jack.ngo,
 nooromari@jack.ngo,
 pharmacy.assistant@jack.ngo,
 pharmacy@jack.ngo,
 takal@jack.ngo
Delivery-date: Wed, 05 May 2021 01:50:59 -0400
From: <hadi@jack.ngo>
To: <pharmacy@jack.ngo>,
	<dr.safar@jack.ngo>,
	<pharmacy.assistant@jack.ngo>,
	<hamdard@jack.ngo>
Cc: <ahmad@jack.ngo>,
	<ghani@jack.ngo>,
	<takal@jack.ngo>,
	<mirzaee@jack.ngo>,
	<ahf-finance@jack.ngo>,
	<musawy@jack.ngo>,
	<nooromari@jack.ngo>,
	<fatima.qasimi@jack.ngo>,
	<logistic.manager@jack.ngo>,
	<finance.advisor@jack.ngo>
References: <007701d719a6$5153c930$f3fb5b90$@jack.ngo> <!&!AAAAAAAAAAAuAAAAAAAAAK+whLNHJnZLnYDb4fLeB80BAMO2jhD3dRHOtM0AqgC7tuYAAAAAAA4AABAAAADn+wNFvFnYSoPoAS9WN/N/AQAAAAA=@jack.ngo> <005e01d74040$648d85c0$2da89140$@jack.ngo> <!&!AAAAAAAAAAAuAAAAAAAAAK+whLNHJnZLnYDb4fLeB80BAMO2jhD3dRHOtM0AqgC7tuYAAAAAAA4AABAAAACep1eA9bOhTIfFy9Hssf6mAQAAAAA=@jack.ngo>
In-Reply-To: <!&!AAAAAAAAAAAuAAAAAAAAAK+whLNHJnZLnYDb4fLeB80BAMO2jhD3dRHOtM0AqgC7tuYAAAAAAA4AABAAAACep1eA9bOhTIfFy9Hssf6mAQAAAAA=@jack.ngo>
Subject: RE: Rejected and not received medicine
Date: Wed, 5 May 2021 01:50:59 -0400
Message-ID: <002a01d74172$a04a9ac0$e0dfd040$@jack.ngo>
MIME-Version: 1.0
Content-Type: multipart/related;
	boundary="----=_NextPart_000_002B_01D74151.193D1970"
Thread-Index: AQIwKTvpzDoM5QD4M3IF3aqBB1HSrgHFTt8gAVPZ+SsBTSLbp6n/XFTg
Content-Language: en-us

This is a multipart message in MIME format.

------=_NextPart_000_002B_01D74151.193D1970
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_002C_01D74151.193D1970"

------=_NextPart_001_002C_01D74151.193D1970
Content-Type: text/plain;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

Dear Colleagues,

=20

Greetings of the day:

=20

The issue should be solve using our resources, so please communicate =
with the AOGs and try to resolve the issue ASAP.

=20

It is getting late because the project officially closed on April 30th, =
so please expedite the communication process and come up with a =
reasonable solution.

=20

Dear Doctor Sahib Jamal and Mrs. Qasimi,

=20

At this point under AHF Trauma we cannot cover the deference the only =
option we have is to cover the deference from the salaries of =
responsible persons if incase we did not receive back the medicine =
within next few days, so please consider the said issue before transfer =
their salaries.

Regards,

Hadi =20

=20

From: pharmacy@jack.ngo <pharmacy@jack.ngo>=20
Sent: Tuesday, May 4, 2021 4:58 AM
To: dr.safar@jack.ngo; pharmacy.assistant@jack.ngo; hamdard@jack.ngo
Cc: ahmad@jack.ngo; hadi@jack.ngo; ghani@jack.ngo; takal@jack.ngo; =
mirzaee@jack.ngo; ahf-finance@jack.ngo; musawy@jack.ngo; =
nooromari@jack.ngo
Subject: RE: Rejected and not received medicine

=20

Dear Dr. Sahib Safar,

=20

Thanks from your email and justifications, the attached informal GRN =
shows that the medicines delivered to supplier without pharmacy =
committee and incomplete, but KDZ-AHF team promised to deliver complete =
rejected amount to supplier, the financial cost of this exchange was and =
will be:

1.       Complete exchange cost: 23,530 AFN=20

2.       Incomplete exchange cost: 41,590 AFN

As now the medicine delivered to supplier incompletely, I would like to =
know how we should pay 41,590 AFN to supplier, looking forward to hear =
from you soon.

=20

Dear En. Sahib Hadi,

=20

Kindly refer to below emails and let us know your comments.

=20

Regards

Jamal

=20

From: dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> =
[mailto:dr.safar@jack.ngo]=20
Sent: Monday, May 3, 2021 9:49 PM
To: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> ; =
pharmacy.assistant@jack.ngo <mailto:pharmacy.assistant@jack.ngo> ; =
hamdard@jack.ngo <mailto:hamdard@jack.ngo>=20
Cc: ahmad@jack.ngo <mailto:ahmad@jack.ngo> ; hadi@jack.ngo =
<mailto:hadi@jack.ngo> ; ghani@jack.ngo <mailto:ghani@jack.ngo> ; =
takal@jack.ngo <mailto:takal@jack.ngo> ; mirzaee@jack.ngo =
<mailto:mirzaee@jack.ngo> ; ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> ; musawy@jack.ngo <mailto:musawy@jack.ngo> =
; nooromari@jack.ngo <mailto:nooromari@jack.ngo>=20
Subject: RE: Rejected and not received medicine

=20

Dear Dr Jamal

=20

As per investigations, I found out there are two problems.

1.       Only 295 flagyl syrups were submitted to Supplier, in this =
case, Haji Naim Jan clininc flagyl syrup were not received although =
Pharmacy assistant delivered Metrogyls, however he says the AOG =
responsible did not give me flagyl syrups

2.       When we delivered the sample medicine to Jan Qataghan of =
Khanabad district for AOG check up, the Salin 500 Ml syrums were sent as =
well, however after rejection, they were not collected back, due to AOG =
said rejected medicine should be replaced in FATP. When we wanted to =
deliver the 1000 Ml syrums of Salin, the pharmacy assistant did not =
collected salin 500 ml back. Then the ban started from march 12 =
=E2=80=93 2021 1st May 2021. Now when he called to the AOGs that we want =
our 450 Salin 500 mL syrums back, then AOG responsible replied that =
=E2=80=9Cnot collecting back the serums were NGOs fault and now we will =
not give it back we have sealed those serums and we will use it for our =
purpose=E2=80=9D.

=20

The conclusion: Two times the medicine were sent, however they were not =
collected back by Pharmacy assistant.=20

=20

The rest of the decision is up to Kabul Management team what they =
decide, the cleareance of each and every staff is up hold, the decision =
on this section is easy if the AOGs do not give us back serums and =
flagyl syrups.

=20

Currently I am communicating through community access mobilizer, will =
share the result of what is the final words of AOGs by tomorrow CoB.

=20

Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D MD/GP/Social Service Provider

Project Manager-AHF Project

Just for Afghan Capacity and Knowledge       =D8=A8=D9=84=D9=86=D8=AF =
=D8=A8=D8=B1=D8=AF=D9=86 =D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =
=D9=88 =D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9) =20

Address: Kunduz,Kocha Sinama,First Region

Beside Da Afghanistan Bank, House # 08

Ph: +93 787 047 554 - +93 744 990 143 - +93792711163

Email: <mailto:Dr.Safar@jack.ngo> Dr.Safar@jack.ngo

Email: <mailto:Parvez.Safar@gmail.com> Parvez.Safar@gmail.com=20

Website:www.jack.ngo

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> =
[mailto:pharmacy@jack.ngo]=20
Sent: Monday, May 3, 2021 1:18 PM
To: dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> ; =
pharmacy.assistant@jack.ngo <mailto:pharmacy.assistant@jack.ngo> ; =
hamdard@jack.ngo <mailto:hamdard@jack.ngo>=20
Cc: ahmad@jack.ngo <mailto:ahmad@jack.ngo> ; hadi@jack.ngo =
<mailto:hadi@jack.ngo> ; ghani@jack.ngo <mailto:ghani@jack.ngo> ; =
takal@jack.ngo <mailto:takal@jack.ngo> ; mirzaee@jack.ngo =
<mailto:mirzaee@jack.ngo> ; ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> ; musawy@jack.ngo <mailto:musawy@jack.ngo> =
; nooromari@jack.ngo <mailto:nooromari@jack.ngo>=20
Subject: RE: Rejected and not received medicine

=20

Gentle Reminder!

=20

Dear AHF Team need your response regarding the subject issue, also let =
us know the way you delivered medicine to supplier along with delivered =
amount, looking forward to hear from you soon.

=20

Regards

Jamal

=20

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> =
[mailto:pharmacy@jack.ngo]=20
Sent: Saturday, May 1, 2021 1:53 PM
To: 'dr.safar@jack.ngo' <dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> >; =
'pharmacy.assistant@jack.ngo' <pharmacy.assistant@jack.ngo =
<mailto:pharmacy.assistant@jack.ngo> >; 'hamdard@jack.ngo' =
<hamdard@jack.ngo <mailto:hamdard@jack.ngo> >
Cc: 'ahmad@jack.ngo' <ahmad@jack.ngo <mailto:ahmad@jack.ngo> >; =
'hadi@jack.ngo' <hadi@jack.ngo <mailto:hadi@jack.ngo> >; =
'ghani@jack.ngo' <ghani@jack.ngo <mailto:ghani@jack.ngo> >; =
'takal@jack.ngo' <takal@jack.ngo <mailto:takal@jack.ngo> >; =
'mirzaee@jack.ngo' <mirzaee@jack.ngo <mailto:mirzaee@jack.ngo> >; =
'ahf-finance@jack.ngo' <ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> >; 'musawy@jack.ngo' <musawy@jack.ngo =
<mailto:musawy@jack.ngo> >
Subject: RE: Rejected and not received medicine

=20

Dear Dr. Safar and Amrullah Khan,

=20

I hope you have been well, based on your request and top management =
approval we have exchanged the rejected medicine to requested medicine =
which your all fully aware of that, now we have pay 23,530 AFN to =
supplier due to exchange rate, to let you know finance team will pay the =
main procurement cost to supplier only exchange cost rate will be paid =
by you as it was agreed, attached is the supplier bank details, if there =
be any question please contact to finance team.

=20

Regards

Jamal

=20

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> =
[mailto:pharmacy@jack.ngo]=20
Sent: Tuesday, March 30, 2021 10:26 AM
To: 'dr.safar@jack.ngo' <dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> >; =
'pharmacy.assistant@jack.ngo' <pharmacy.assistant@jack.ngo =
<mailto:pharmacy.assistant@jack.ngo> >; 'hamdard@jack.ngo' =
<hamdard@jack.ngo <mailto:hamdard@jack.ngo> >
Cc: 'ahmad@jack.ngo' <ahmad@jack.ngo <mailto:ahmad@jack.ngo> >; =
'hadi@jack.ngo' <hadi@jack.ngo <mailto:hadi@jack.ngo> >; =
'ghani@jack.ngo' <ghani@jack.ngo <mailto:ghani@jack.ngo> >; =
'takal@jack.ngo' <takal@jack.ngo <mailto:takal@jack.ngo> >; =
'mirzaee@jack.ngo' <mirzaee@jack.ngo <mailto:mirzaee@jack.ngo> >; =
'ahf-finance@jack.ngo' <ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> >; 'musawy@jack.ngo' <musawy@jack.ngo =
<mailto:musawy@jack.ngo> >
Subject: RE: Rejected and not received medicine

=20

Dear Dr. Safar,

=20

I am glad that you received the requested medicine for 4th Qtr of AHF =
project, which I didn=E2=80=99t get your confirmation nor GRN, please =
let me know about following comments:

1.       Vicryl 4/1 is not available at the market, which size will be =
the alternative (Vicryl size 4 or Vicryl size 1).

2.       Per your request and senior management approval we discussed =
and agreed with supplier to exchange the two rejected items =
(Serum-Saline 500ml & Syrup-Metro 200mg/30ml) to requested items =
(Serum-Saline 1000ml & Serum-Metro 500mg/30ml) beyond the main contract, =
now supplier is confused that when I will receive the exchanged items =
because he already send his representative three times to PO-M.Stock, in =
order to receive the exchange medicine but due to none reason the =
process get postponed, I would like to know if there is any problem and =
the exact time when your able to deliver the exchanged items to =
supplier.

Please let me know if there is anything that I can help you to =
accelerate the process and close the procurement process.

=20

Best Regards,

=20

JAMAL   Pharm.D

Procurement / Pharmacy Manger

Address: 1st Street of Karta-e-Chahar, Kabul Afghanistan=20

Behind AWCC Main Office, House # 09

What=E2=80=99s app: +93 744 402 619

Email: pharm.dmrjamal@gmail.com <mailto:pharm.dmrjamal@gmail.com> =20

Website:www.jack.ngo=20

=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D

This e-mail and any files transmitted with it may contain privileged or =
confidential information. It is solely for use by the individual for =
whom it is intended, even if addressed incorrectly. If you received this =
e-mail in error, please notify the sender; do not disclose copy, =
distribute, or take any action in reliance on the contents of this =
information; and delete it from your system. Any other use of this =
e-mail is prohibited. The views expressed herein are those of the author =
and do not necessarily reflect the views or policies of jack =
(Afghanistan). Electronic transmissions may be recorded and =
monitored.For Verification Please Read the Barcode Reader. =20

=09
	=09
=20

=20

P Every 3000 sheets of paper costs us a tree. Please don't print this =
e-mail unless you really need to

=20

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> =
[mailto:pharmacy@jack.ngo]=20
Sent: Tuesday, March 16, 2021 10:13 AM
To: 'dr.safar@jack.ngo' <dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> >; =
'pharmacy.assistant@jack.ngo' <pharmacy.assistant@jack.ngo =
<mailto:pharmacy.assistant@jack.ngo> >; 'hamdard@jack.ngo' =
<hamdard@jack.ngo <mailto:hamdard@jack.ngo> >
Cc: 'ahmad@jack.ngo' <ahmad@jack.ngo <mailto:ahmad@jack.ngo> >; =
'hadi@jack.ngo' <hadi@jack.ngo <mailto:hadi@jack.ngo> >; =
'ghani@jack.ngo' <ghani@jack.ngo <mailto:ghani@jack.ngo> >; =
'takal@jack.ngo' <takal@jack.ngo <mailto:takal@jack.ngo> >; =
'mirzaee@jack.ngo' <mirzaee@jack.ngo <mailto:mirzaee@jack.ngo> >; =
'ahf-finance@jack.ngo' <ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> >; 'musawy@jack.ngo' <musawy@jack.ngo =
<mailto:musawy@jack.ngo> >
Subject: RE: Rejected and not received medicine

=20

Dear Dr. Sahib Safar,

=20

Thanks from your email, please review below comments:

1.       I received the draft of GRN and I found difference at 11 items, =
as I shared the list with supplier he send his representative to PO to =
solve the supply issue immediately, again I will follow this issue with =
supplier and will communicate you via phone.

2.       As we have agreed with supplier to exchange the two items which =
are quarantine right now at P-Stock and you received the replacement, =
please make them ready and pack in exact Qty and good package, please do =
the exchange process in presence of pharmacy committee.

3.       As I already talked with pharmacy team, so please inform them =
to prepare the GRN with all required info such as (expiry date, batch =
number, company & country, Qty, etc..).

4.       As you all aware that AHF-Projects will be audit by 3rd party =
team, so please inform the AHF pharmacy in charge to fully get ready for =
assessment.

=20

Regards

Jamal

=20

From: dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> =
[mailto:dr.safar@jack.ngo]=20
Sent: Monday, March 15, 2021 6:50 PM
To: logitic.manager@jack.ngo <mailto:logitic.manager@jack.ngo>=20
Cc: ahmad@jack.ngo <mailto:ahmad@jack.ngo> ; hadi@jack.ngo =
<mailto:hadi@jack.ngo> ; ghani@jack.ngo <mailto:ghani@jack.ngo> ; =
takal@jack.ngo <mailto:takal@jack.ngo> ; mirzaee@jack.ngo =
<mailto:mirzaee@jack.ngo> ; ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> ; pharmacy@jack.ngo =
<mailto:pharmacy@jack.ngo>=20
Subject: Rejected and not received medicine

=20

Dear Dr Sahib Jamal

Greetings from Kunduz office

=20

First of all thank you very much for a very quick procurement of AHF =
trauma medicine, the quality and the quantitiy is good and appreciated.

=20

However, there are difference in 11 items, as we explained and the =
report was shared with the pharmacy/warehouse responsible. I hope it has =
reached to you and I would like to kindly request on the process speed =
up.=20

=20

I would be glad to hear from your dear dr Sahib.

=20

Thank you & Best Regards

=20

Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D MD/GP/Social Service Provider

Project Manager-AHF Project / NER PSEA Focal Point / Mental Health Focal =
Point

Address: Kunduz,Kocha Sinama,First Region

Beside Da Afghanistan Bank, House # 08

Ph: +93 787 047 554 - +93 744 990 143 - +93792 716 026 =E2=80=93 +93777 =
469 663 =E2=80=93 +93706 179 758

Official Email: <mailto:Dr.Safar@jack.ngo> Dr.Safar@jack.ngo

Personal Email: <mailto:Dr.Safar001@outlook.com> =
Dr.Safar001@outlook.com =E2=80=93 <mailto:Dr.Safar@yahoo.com> =
Dr.Safar@yahoo.com

Website:www.jack.ngo

=20

------=_NextPart_001_002C_01D74151.193D1970
Content-Type: text/html;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" =
xmlns:o=3D"urn:schemas-microsoft-com:office:office" =
xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" =
xmlns=3D"http://www.w3.org/TR/REC-html40"><head><meta =
http-equiv=3DContent-Type content=3D"text/html; charset=3Dutf-8"><meta =
name=3DGenerator content=3D"Microsoft Word 15 (filtered medium)"><style></style></head><body lang=3DEN-US =
link=3D"#0563C1" vlink=3D"#954F72"><div class=3DWordSection1>Dear =
Colleagues,<o:p></o:p><o:p>&nbsp;</o:p>Greetings of the =
day:<o:p></o:p><o:p>&nbsp;</o:p>The issue should be =
solve using our resources, so please communicate with the AOGs and try =
to resolve the issue ASAP.<o:p></o:p><o:p>&nbsp;</o:p>It is getting late =
because the project officially closed on April 30th, so =
please expedite the communication process and come up with a reasonable =
solution.<o:p></o:p><o:p>&nbsp;</o:p>Dear Doctor Sahib Jamal =
and Mrs. Qasimi,<o:p></o:p><o:p>&nbsp;</o:p>At this point under AHF =
Trauma we cannot cover the deference the only option we have is to cover =
the deference from the salaries of responsible persons if incase we did =
not receive back the medicine within next few days, so please consider =
the said issue before transfer their =
salaries. <o:p></o:p>Regards,<o:p></o:p>Hadi =
=C2=A0<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: pharmacy@jack.ngo =
&lt;pharmacy@jack.ngo&gt; Sent: Tuesday, May 4, 2021 4:58 =
AM To: dr.safar@jack.ngo; pharmacy.assistant@jack.ngo; =
hamdard@jack.ngo Cc: ahmad@jack.ngo; hadi@jack.ngo; =
ghani@jack.ngo; takal@jack.ngo; mirzaee@jack.ngo; ahf-finance@jack.ngo; =
musawy@jack.ngo; nooromari@jack.ngo Subject: RE: Rejected and =
not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. Sahib Safar,<o:p></o:p><o:p>&nbsp;</o:p>Thanks from your email =
and justifications, the attached informal GRN shows that the medicines =
delivered to supplier without pharmacy committee and incomplete, but =
KDZ-AHF team promised to deliver complete rejected amount to supplier, =
the financial cost of this exchange was and will =
be:<o:p></o:p><![if =
!supportLists]>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Complete exchange cost: 23,530 AFN =
<o:p></o:p><![if =
!supportLists]>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Incomplete exchange cost: 41,590 =
AFN<o:p></o:p>As now the medicine delivered to supplier =
incompletely, I would like to know how we should pay 41,590 AFN to =
supplier, looking forward to hear from you soon.<o:p></o:p><o:p>&nbsp;</o:p>Dear En. Sahib =
Hadi,<o:p></o:p><o:p>&nbsp;</o:p>Kindly refer to below =
emails and let us know your comments.<o:p></o:p><o:p>&nbsp;</o:p>Regards<o:p></o:p>Jamal<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a> [<a =
href=3D"mailto:dr.safar@jack.ngo">mailto:dr.safar@jack.ngo</a>] =
 Sent: Monday, May 3, 2021 9:49 PM To: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a>; <a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>; <a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a> Cc: <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>; <a =
href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; <a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>; <a =
href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>; <a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>; <a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>; <a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>; <a =
href=3D"mailto:nooromari@jack.ngo">nooromari@jack.ngo</a> Subject:<=
/b> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr Jamal<o:p></o:p><o:p>&nbsp;</o:p>As per investigations, I =
found out there are two problems.<o:p></o:p><![if !supportLists]>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Only 295 flagyl syrups were submitted to =
Supplier, in this case, Haji Naim Jan clininc flagyl syrup were not =
received although Pharmacy assistant delivered Metrogyls, however he =
says the AOG responsible did not give me flagyl =
syrups<o:p></o:p><![if =
!supportLists]>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>When we delivered the sample medicine to Jan =
Qataghan of Khanabad district for AOG check up, the Salin 500 Ml syrums =
were sent as well, however after rejection, they were not collected =
back, due to AOG said rejected medicine should be replaced in FATP. When =
we wanted to deliver the 1000 Ml syrums of Salin, the pharmacy assistant =
did not collected salin 500 ml back. Then the ban started from march 12 =
=E2=80=93 2021 1st May 2021. Now when he called to the AOGs =
that we want our 450 Salin 500 mL syrums back, then AOG responsible =
replied that =E2=80=9Cnot collecting back the serums were NGOs fault and =
now we will not give it back we have sealed those serums and we will use =
it for our purpose=E2=80=9D.<o:p></o:p><o:p>&nbsp;</o:p>The conclusion: Two =
times the medicine were sent, however they were not collected back by =
Pharmacy assistant. <o:p></o:p><o:p>&nbsp;</o:p>The rest of the decision =
is up to Kabul Management team what they decide, the cleareance of each =
and every staff is up hold, the decision on this section is easy if the =
AOGs do not give us back serums and flagyl =
syrups.<o:p></o:p><o:p>&nbsp;</o:p>Currently I am =
communicating through community access mobilizer, will share the result =
of what is the final words of AOGs by tomorrow =
CoB.<o:p></o:p><o:p>&nbsp;</o:p>Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D =
MD/GP/Social Service =
Provider<o:p></o:p>Project Manager-AHF =
Project<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: Kunduz,Kocha Sinama,First =
Region<o:p></o:p>Beside Da Afghanistan Bank, House # =
08<o:p></o:p>Ph: +93 787 047 554 - +93 744 990 143 - =
+93792711163<o:p></o:p>Email: <a =
href=3D"mailto:Dr.Safar@jack.ngo">Dr.Safar@jack.ngo</a><o:p></o:p>Email: <a =
href=3D"mailto:Parvez.Safar@gmail.com">Parvez.Safar@gmail.com</a> <o:p></o:p>Website:www.jack.ngo<o:p></o:p><=
div><div style=3D'border:none;border-top:solid #E1E1E1 =
1.0pt;padding:3.0pt 0in 0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Monday, May 3, 2021 1:18 PM To: <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>; <a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>; <a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a> Cc: <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>; <a =
href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; <a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>; <a =
href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>; <a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>; <a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>; <a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>; <a =
href=3D"mailto:nooromari@jack.ngo">nooromari@jack.ngo</a> Subject:<=
/b> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Gentle Reminder!<o:p></o:p><o:p>&nbsp;</o:p>Dear AHF Team need your =
response regarding the subject issue, also let us know the way you =
delivered medicine to supplier along with delivered amount, looking =
forward to hear from you soon.<o:p></o:p><o:p>&nbsp;</o:p>Regards<o:p></o:p>Jamal<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Saturday, May 1, 2021 1:53 PM To: =
'dr.safar@jack.ngo' &lt;<a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>&gt;; =
'pharmacy.assistant@jack.ngo' &lt;<a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>&gt;; 'hamdard@jack.ngo' &lt;<a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>&gt; Cc: =
'ahmad@jack.ngo' &lt;<a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&gt;; 'hadi@jack.ngo' =
&lt;<a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>&gt;; =
'ghani@jack.ngo' &lt;<a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>&gt;; 'takal@jack.ngo' =
&lt;<a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>&gt;; =
'mirzaee@jack.ngo' &lt;<a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>&gt;; =
'ahf-finance@jack.ngo' &lt;<a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>&gt;; =
'musawy@jack.ngo' &lt;<a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>&gt; Subject:</b=
> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. Safar and Amrullah =
Khan,<o:p></o:p><o:p>&nbsp;</o:p>I hope you have been =
well, based on your request and top management approval we have =
exchanged the rejected medicine to requested medicine which your all =
fully aware of that, now we have pay 23,530 AFN to supplier due to =
exchange rate, to let you know finance team will pay the main =
procurement cost to supplier only exchange cost rate will be paid by you =
as it was agreed, attached is the supplier bank details, if there be any =
question please contact to finance team.<o:p></o:p><o:p>&nbsp;</o:p>Regards<o:p></o:p>Jamal<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Tuesday, March 30, 2021 10:26 AM To: =
'dr.safar@jack.ngo' &lt;<a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>&gt;; =
'pharmacy.assistant@jack.ngo' &lt;<a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>&gt;; 'hamdard@jack.ngo' &lt;<a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>&gt; Cc: =
'ahmad@jack.ngo' &lt;<a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&gt;; 'hadi@jack.ngo' =
&lt;<a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>&gt;; =
'ghani@jack.ngo' &lt;<a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>&gt;; 'takal@jack.ngo' =
&lt;<a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>&gt;; =
'mirzaee@jack.ngo' &lt;<a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>&gt;; =
'ahf-finance@jack.ngo' &lt;<a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>&gt;; =
'musawy@jack.ngo' &lt;<a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>&gt; Subject:</b=
> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. Safar,<o:p></o:p><o:p>&nbsp;</o:p>I am glad that you =
received the requested medicine for 4th Qtr of AHF project, =
which I didn=E2=80=99t get your confirmation nor GRN, please let me know =
about following comments:<o:p></o:p><![if !supportLists]>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Vicryl 4/1 is not available at the market, which =
size will be the alternative (Vicryl size 4 or Vicryl size =
1).<o:p></o:p><![if =
!supportLists]>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Per your request and senior management approval =
we discussed and agreed with supplier to exchange the two rejected items =
(Serum-Saline 500ml &amp; Syrup-Metro 200mg/30ml) to requested items =
(Serum-Saline 1000ml &amp; Serum-Metro 500mg/30ml) beyond the main =
contract, now supplier is confused that when I will receive the =
exchanged items because he already send his representative three times =
to PO-M.Stock, in order to receive the exchange medicine but due to none =
reason the process get postponed, I would like to know if there is any =
problem and the exact time when your able to deliver the exchanged items =
to supplier.<o:p></o:p>Please let me know if there is anything that I =
can help you to accelerate the process and close the procurement =
process.<o:p></o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p>Best =
Regards,<o:p></o:p><o:p>&nbsp;</o:p><img border=3D0 =
width=3D49 height=3D38 style=3D'width:.5125in;height:.3958in' =
id=3D"_x0000_i1033" src=3D"cid:image001.jpg@01D7414F.93048DD0" =
alt=3D"cid:image003.jpg@01D4B669.F250F440"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>JAMAL&nbsp;&nbsp; Pharm.D<o:p></o:p>Procurement / Pharmacy =
Manger<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: 1st Street of Karta-e-Chahar, =
Kabul Afghanistan <o:p></o:p>Behind AWCC Main Office, House # =
09<o:p></o:p>What=E2=80=99s app: +93 744 402 =
619<o:p></o:p>Email: <a =
href=3D"mailto:pharm.dmrjamal@gmail.com">pharm.dmrjamal@gmail.com</a></sp=
an>&nbsp; <o:p></o:p>Website:www.jack.ngo <o:p></o:p>=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
<o:p></o:p>This e-mail and any files =
transmitted with it may contain privileged or confidential information. =
It is solely for use by the individual for whom it is intended, even if =
addressed incorrectly. If you received this e-mail in error, please =
notify the sender; do not disclose copy, distribute, or take any action =
in reliance on the contents of this information; and delete it from your =
system. Any other use of this e-mail is prohibited. The views expressed =
herein are those of the author and do not necessarily reflect the views =
or policies of jack (Afghanistan). Electronic transmissions may be =
recorded and monitored.For Verification Please Read =
the Barcode Reader.&nbsp; <o:p></o:p><![if !vml]><table cellpadding=3D0 cellspacing=3D0 =
align=3Dleft><tr><td width=3D11 =
height=3D7608></td></tr><tr><td></td><td><img width=3D92 height=3D92 =
style=3D'width:.9583in;height:.9583in' =
src=3D"cid:image004.jpg@01D7414F.93048DD0" alt=3D"jack smart code" =
v:shapes=3D"Picture_x0020_1"></td></tr></table><![endif]><o:p>&nbsp;</o:p></=
p><o:p>&nbsp;</o:p><o:p>&nbsp;</=
o:p><o:p>&nbsp;</=
o:p> P<s=
pan =
style=3D'font-size:7.5pt;font-family:"Arial",sans-serif;color:green'> =
Ever=
y 3000 sheets of paper costs us a tree. Please don't print this e-mail =
unless you really need to<o:p></o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Tuesday, March 16, 2021 10:13 AM To: =
'dr.safar@jack.ngo' &lt;<a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>&gt;; =
'pharmacy.assistant@jack.ngo' &lt;<a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>&gt;; 'hamdard@jack.ngo' &lt;<a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>&gt; Cc: =
'ahmad@jack.ngo' &lt;<a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&gt;; 'hadi@jack.ngo' =
&lt;<a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>&gt;; =
'ghani@jack.ngo' &lt;<a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>&gt;; 'takal@jack.ngo' =
&lt;<a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>&gt;; =
'mirzaee@jack.ngo' &lt;<a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>&gt;; =
'ahf-finance@jack.ngo' &lt;<a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>&gt;; =
'musawy@jack.ngo' &lt;<a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>&gt; Subject:</b=
> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. Sahib Safar,<o:p></o:p><o:p>&nbsp;</o:p>Thanks from your email, =
please review below comments:<o:p></o:p><![if !supportLists]>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>I received the draft of GRN and I found =
difference at 11 items, as I shared the list with supplier he send his =
representative to PO to solve the supply issue immediately, again I will =
follow this issue with supplier and will communicate you via =
phone.<o:p></o:p><![if =
!supportLists]>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>As we have agreed with supplier to exchange the =
two items which are quarantine right now at P-Stock and you received the =
replacement, please make them ready and pack in exact Qty and good =
package, please do the exchange process in presence of pharmacy =
committee.<o:p></o:p><![if =
!supportLists]>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>As I already talked with pharmacy team, so =
please inform them to prepare the GRN with all required info such as =
(expiry date, batch number, company &amp; country, Qty, =
etc..).<o:p></o:p><![if =
!supportLists]>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>As you all aware that AHF-Projects will be audit =
by 3rd party team, so please inform the AHF pharmacy in =
charge to fully get ready for assessment.<o:p></o:p><o:p>&nbsp;</o:p>Regards<o:p></o:p>Jamal<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a> [<a =
href=3D"mailto:dr.safar@jack.ngo">mailto:dr.safar@jack.ngo</a>] =
 Sent: Monday, March 15, 2021 6:50 PM To: <a =
href=3D"mailto:logitic.manager@jack.ngo">logitic.manager@jack.ngo</a> =
Cc: <a href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>; <a =
href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; <a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>; <a =
href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>; <a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>; <a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>; <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> Subject:</b=
> Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr =
Sahib Jamal<o:p></o:p>Greetings from Kunduz =
office<o:p></o:p><o:p>&nbsp;</o:p>First of all thank you very much for a very quick =
procurement of AHF trauma medicine, the quality and the quantitiy is =
good and appreciated.<o:p></o:p><o:p>&nbsp;</o:p>However, =
there are difference in 11 items, as we explained and the report was =
shared with the pharmacy/warehouse responsible. I hope it has reached to =
you and I would like to kindly request on the process speed up. =
<o:p></o:p><o:p>&nbsp;</o:p>I would be glad to hear from your dear dr =
Sahib.<o:p></o:p><o:p>&nbsp;</o:p>Thank you &amp; Best =
Regards<o:p></o:p><img border=3D0 width=3D49 =
height=3D38 style=3D'width:.5125in;height:.3958in' id=3D"_x0000_i1034" =
src=3D"cid:image005.jpg@01D7414F.93048DD0"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D =
MD/GP/Social Service =
Provider<o:p></o:p>Project Manager-AHF Project / NER PSEA =
Focal Point / Mental Health Focal Point<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: Kunduz,Kocha Sinama,First =
Region<o:p></o:p>Beside Da Afghanistan Bank, House # =
08<o:p></o:p>Ph: +93 787 047 554 - +93 744 990 143 - =
+93792 716 026 =E2=80=93 +93777 469 663 =E2=80=93 +93706 179 =
758<o:p></o:p>Official Email: <a =
href=3D"mailto:Dr.Safar@jack.ngo">Dr.Safar@jack.ngo</a><o:p></o:p>Personal Email: <a =
href=3D"mailto:Dr.Safar001@outlook.com">Dr.Safar001@outlook.com</a> =
=E2=80=93 <a href=3D"mailto:Dr.Safar@yahoo.com">Dr.Safar@yahoo.com</a><o:p></o:p>Website:www.jack.ngo<o:p></o:p><=
p class=3DMsoNormal><o:p>&nbsp;</o:p></div></body></html>
------=_NextPart_001_002C_01D74151.193D1970--

------=_NextPart_000_002B_01D74151.193D1970
Content-Type: image/jpeg;
	name="image001.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image001.jpg@01D7414F.93048DD0>
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------=_NextPart_000_002B_01D74151.193D1970
Content-Type: image/png;
	name="image002.png"
Content-Transfer-Encoding: base64
Content-ID: <image002.png@01D7414F.93048DD0>

iVBORw0KGgoAAAANSUhEUgAAASIAAAEiAQAAAAB1xeIbAAAABGdBTUEAALGOfPtRkwAAAAlwSFlz
AAAOxAAADsQBlSsOGwAAABl0RVh0U29mdHdhcmUATWljcm9zb2Z0IE9mZmljZX/tNXEAAAEMSURB
VGje7dnBDYMwDIVhSwzASKzOSAxQySWOE1pooIcYqdWfA1LCd3uynVLRL9YsKBQKhfoLJb4GlWkZ
1oOlnEyoaGUbXVw5rS9QoSpFYu/mEpMHhrpNvWSFulvlfoS6UZVc8kC46l+ojup9IufAruY2qova
LQ/s4r6K6qNsDkt52Fbn8bFLCBWgRNJJBqOdPOSYECpEpVaUwZZVHQ2oSOWVYMNYS02oHmoIFaB8
LJemlO9FtURQgcpyWTciZxMZFaGsKW0TuXUTRYUqr4mPv8BQkcqnQuOrDypClcKonQl1n7I7kKl0
L2p+7UT1V7kf5RIZtfUPCypEWS5bOM2JjOqvzhcKhUKhfl49AcZAJK+rvDc4AAAAAElFTkSuQmCC

------=_NextPart_000_002B_01D74151.193D1970
Content-Type: image/jpeg;
	name="image004.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image004.jpg@01D7414F.93048DD0>
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------=_NextPart_000_002B_01D74151.193D1970
Content-Type: image/jpeg;
	name="image005.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image005.jpg@01D7414F.93048DD0>
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------=_NextPart_000_002B_01D74151.193D1970--